GlassScriptPhysician profile
Diane Hunt
NPI 1073589701
$6,810.77
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,134 · 2021: $181 · 2022: $172 · 2023: $146 · 2024: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,174.84 | 2019-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $129.99 | 2024 | Spyglass Discover |
| Leica Microsystems INC. | $109.97 | 2021 | |
| Zimmer Biomet Holdings, INC. | $108.95 | 2022 | |
| Hologic INC | $70.99 | 2021 | |
| Teleflex LLC | $40.46 | 2022 | |
| Conmed Corporation | $33.63 | 2023 | Airseal |
| Edwards Lifesciences Corporation | $23.00 | 2022 | |
| Apollo Endosurgery US INC | $22.15 | 2019 | |
| Avanos Medical | $21.98 | 2023 | Pnb and Accessories |
| Kub Technologies INC. | $19.25 | 2024 | |
| Ethicon US, LLC | $14.56 | 2019 | |
| Solventum Corporation | $14.43 | 2024 | V.A.C. Veraflo, V.A.C.Ulta |
| Aroa Biosurgery Incorporated | $13.73 | 2024 | |
| Kls-Martin L.P. | $12.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.